Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In HEXO Corp. To Contact The Firm 

Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in HEXO Corp. (“HEXO” or the “Company”) (NYSE:HEXO) of the January 27, 2020 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. 

If you invested in HEXO stock or options between January 25, 2019 and November 15, 2019 and would like to discuss your legal rights, please fill out the form below. There is no cost or obligation to you. You can also contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.  

The lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of all those who purchased HEXO common stock between January 25, 2019 and November 15, 2019 (the “Class Period”).  The case, Perez v. HEXO Corp. et al., No. 19-cv-10965 was filed on November 26, 2019.

The lawsuit focuses on whether the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) HEXO's reported inventory was  misstated as the Company was failing to write down or write off obsolete product that no  longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue  figures and meet or exceed revenue guidance provided to investors; and (3) HEXO was cultivating  cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada. 

On October 4, 2019, HEXO announced the abrupt and immediate resignation of its then-Chief Financial Officer, Michael Monahan. This resignation came just a few months into the job. 

On this news, the Company's stock price fell from $4.06 per share on October 4, 2019 to $3.80 per share on October 7, 2019: a $0.26 or 6.40% drop.

Then, on October 10, 2019, HEXO issued a press release providing preliminary Q4 2019 revenue results and withdrew its fiscal year 2020 outlook. In the release, the Company stated that they expected HEXO's net revenue for the fourth quarter to be $14.5 million to $16.5 million, well below previous guidance that called for CAD$24.8 million. 

On this news, the Company's stock price fell from $3.68 per share on October 10, 2019 to $2.85 per share on October 10, 2019: a $0.83 or 22.45% drop.

On October 24, 2019, HEXO announced 200 layoffs. which resulted in the subsequent shutting down 11 of several facilities it operated near Niagara Falls, Ontario. Significantly, the cuts included the elimination of executive positions and the departures of Amo Groll, Chief Manufacturing Officer and Nick Davies, Chief Marketing Officer. 

On this news, the Company's stock price fell from $2.69 per share on October 24, 2019 to $2.52 per share on October 25, 2019: a $0.17 or 6.31% drop. 

On October 29, 2019, HEXO reported its financial results for the fourth quarter and 2019 fiscal year on Form 40-F, announcing that the Company had taken an impairment on CADS16.9 million of inventory purchased in the prior period, due to declining market prices. The Company further confirmed that "[c]ultivation has been suspended at the Niagara facility."

On this news, the Company's stock price fell from $2.32 per share on October 28, 2019 to $2.25 per share on October 29, 2019: a $0.07 or 3.02% drop.

On November 15, 2019, the Company issued a press release entitled "HEXO Corp provides additional transparency our licensing." admitting that it grew marijuana in an unlicensed facility in Niagara, Ontario previously owned and operated by Newstrike. The Company admitted that on July 30, 2019, after the Newstrike acquisition dosed, HEXO discovered that cannabis was being grown in Block B, which was not. adequately licensed. HEXO management immediately ceased cultivation and production activities in the unlicensed space and notified Health Canada.

On this news, the Company's stock price fell from $1.89 per share on November 14, 2019 to $1.79 per share on November 15, 2019: a $0.10 or 5.29% drop. 

Contact us


Loading captcha, please wait...

* The submission of this form does not create an attorney-client relationship.


Filed on 12/02/2019


Lead Plaintiff Deadline 01/27/2020


685 Third Avenue 26th Floor

10017 New York, New York

Phone (212) 983-9330

Fax (212) 983-9331


Richard W. Gonnello rgonnello@faruqilaw.com Phone (212) 983-9330 Fax (212) 983-9331

Finding us

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331


10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885


3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612


3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534


1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania